Prevencio
Curated by SignalProtein-based diagnostics for cardiovascular diseases
Overview
Prevencio develops protein-based diagnostics and prognostic solutions for cardiovascular diseases. Its flagship assay HART uses proteomics to diagnose coronary artery disease (CAD). Additionally, the test uses protein signatures to determine the risk of myocardial infarction, stroke or cardiovascular death within a year for patients diagnosed with CAD.
Key facts
- Founded
- 2006
- Headquarters
- Kirkland, United States
- Stage
- Sign up to view
- Industry
- Life Sciences Technology
Business model
- 3 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view
- Sign up to view
- Phone
- Sign up to view
Open roles
1 roleSenior Clinical Research Associate / Clinical Research Manager
United States · On-site · Volunteer